Burkina Faso

Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Burkina Faso is regulated by the LNSP (Laboratoire National de Santé Publique). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

LNSP (Laboratoire National de Santé Publique)

Regulatory Pathways (1)

Burkina Faso MOH Special Import Authorization 45 days

Burkina Faso Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Burkina Faso Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Burkina Faso

ISO Code	`BF`
Region	Africa
Regulatory Authority	LNSP (Laboratoire National de Santé Publique)
Pathways	1 documented
Drugs Available	0 documented